2003
Outcomes following Bail-Out abciximab administration during primary intervention in acute myocardial infarction (The CADILLAC Trial)
Ashby DT, Aymong EA, Tcheng JE, Grines CL, Cox DA, Mehran R, Garcia E, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Lansky AJ, Stone GW. Outcomes following Bail-Out abciximab administration during primary intervention in acute myocardial infarction (The CADILLAC Trial). The American Journal Of Cardiology 2003, 92: 1091-1094. PMID: 14583362, DOI: 10.1016/j.amjcard.2003.06.005.Peer-Reviewed Original ResearchMeSH KeywordsAbciximabAgedAngioplasty, Balloon, CoronaryAntibodies, MonoclonalCross-Over StudiesDrug Administration ScheduleFemaleFollow-Up StudiesHumansImmunoglobulin Fab FragmentsIntraoperative ComplicationsMaleMiddle AgedMyocardial InfarctionPlatelet Glycoprotein GPIIb-IIIa ComplexProspective StudiesTreatment FailureConceptsAcute myocardial infarctionMyocardial infarctionGlycoprotein IIb/IIIa receptor inhibitorsUnsuccessful primary percutaneous coronary interventionIIb/IIIa receptor inhibitorsMyocardial Infarction (TIMI) grade 3 flowPrimary percutaneous coronary interventionGrade 3 flowPercutaneous coronary interventionSuboptimal angioplasty resultsAbciximab administrationCADILLAC trialIschemic complicationsControl patientsCoronary interventionProcedural complicationsAngioplasty resultsReceptor inhibitorsPrimary interventionAbciximabPatientsComplicationsInfarctionLower ratesIntervention
1999
Glycoprotein IIb/IIIa Receptor Inhibitors During Primary Angioplasty for Acute Myocardial Infarction.
Gruberg L, Lansky A, Dangas G, Stone G. Glycoprotein IIb/IIIa Receptor Inhibitors During Primary Angioplasty for Acute Myocardial Infarction. Current Interventional Cardiology Reports 1999, 1: 359-367. PMID: 11096642.Peer-Reviewed Original ResearchAcute myocardial infarctionMyocardial infarctionGlycoprotein IIb/IIIa receptor inhibitorsIIb/IIIa receptor inhibitorsPlatelet glycoprotein IIb/IIIa receptorGlycoprotein IIb/IIIa receptor antagonistsGlycoprotein IIb/IIIa receptorIIb/IIIa receptor antagonistsTreatment of AMIIIb/IIIa receptorPrimary mechanical reperfusionAcute coronary syndromeFinal common pathwayIntravenous abciximabMechanical reperfusionCoronary syndromePrimary angioplastyCoronary thrombosisPharmacologic interventionsPercutaneous interventionReceptor antagonistLong-term benefitsPharmacologic agentsReceptor inhibitorsIIIa receptor